Food and Drug Administration, Pharmacology, Physicians and Sales

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Food and Drug Administration

Pharmacology

Physicians

Sales

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain

Legacy MEDSearch

OCTOBER 13, 2022

Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS) system. With HFX iQ, our goal is to provide physicians and patients the personalization needed to achieve and maintain the best possible long-term outcomes. We believe HFX iQ represents the future of SCS therapy.”

FDA

FDA Food and Drug Administration Recruitment Pharmacology

Why aren’t digital pills taking off?

Pharmaceutical Technology

AUGUST 8, 2022

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. Proteus Health’s Abilify MyCite had an ingestible sensor that could track if a patient consumed the drug. Proteus’s profile grew considerably; it was soon valued at $1.5

Food and Drug Administration

Food and Drug Administration FDA Medicine Patients

Pharma Rep Focus

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain

Why aren’t digital pills taking off?

Stay Connected